Article Text

Download PDFPDF
Pharmacotherapy for bipolar depression: comparative efficacy and acceptability is in the eye of the beholder

Statistics from Altmetric.com

Footnotes

  • Competing interests In the past 36 months, LC has engaged in collaborative research with, or received consulting or speaking fees from: Actavis (Forest), Alexza, Alkermes, AstraZeneca, Avanir, Bristol-Myers Squibb, Eli Lilly, Forum, Genentech, Janssen, Jazz, Lundbeck, Merck, Medivation, Mylan, Novartis, Noven, Otsuka, Pfizer, Reckitt Benckiser, Reviva, Shire, Sunovion, Takeda, Teva and Valeant. In the past 36 months, TK has engaged in collaborative research with, or received consulting or speaking fees from: Abbott, Allergan, AstraZeneca, Avanir, Cephalon, Depotmed, Eli Lilly, GlaxoSmithKline, Janssen, Merck, Otsuka, Pfizer and Sunovion. In addition, Dr Ketter's spouse is an employee and stockholder of Janssen.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles